In the last Quarter, GlaxoSmithKline plc (NYSE:GSK) reported its Actual EPS of $0.65/share. In the liquidity ratio analysis; quick ratio for most recent quarter was 0.60 while current ratio for time period was 0.90. Other …
GlaxoSmithKline
GlaxoSmithKline PLC presently has a consensus rating of "Buy" and a consensus target price of $48.00. Based on the brokers price target of …
GlaxoSmithKline plc
Jefferies Group has a “Buy” rating on the stock. Jefferies Group also …
BNS2d
GlaxoSmithKline PLC
The institutional investor owned 22,253 shares of the pharmaceutical …
GlaxoSmithKline PLC
But in the stock market today, Gilead stock slipped a fraction to 67.55, …
HIV Drug
Finally, in consumer healthcare, wellness products saw an increase of 15% to £ 3.7 billion. The stock is trading higher to about $0.35 to $39.78 after …
GSK
Carnegie Capital Asset Management LLC raised its stake in shares of GlaxoSmithKline PLC by 125.8% in the second quarter. The stock touched its high share price of $45.58 on Aug 2, 2016 and the stock also touched …
GlaxoSmithKline
GSK) Drug Manufacturers – Major has a market capitalization valued at Drug Manufacturers – Major. As the outstanding stock of GlaxoSmithKline plc NYSE:GSK Drug Manufacturers – Major is bought and sold in the …
GlaxoSmithKline plc